View in EDS

CSF and amyloid pet biomarker data from scarlet road - a global Phase 3 study of gantenerumab in patients with prodromal AD.

Saved in:

Bibliographic Details
Title:	CSF and amyloid pet biomarker data from scarlet road - a global Phase 3 study of gantenerumab in patients with prodromal AD.
Authors:	Nikolcheva, Tania¹ nikolcheva.t@gmail.com, Lasser, Robert¹, Ostrowitzki, Susanne¹, Scheltens, Philip², Boada, Merce³, Dubois, Bruno⁴, Dorflinger, Ernest¹, Volz, Dietmar¹, Eichenlaub, Udo⁵, Rabe, Christina¹, Bittner, Tobias¹, Schmitz, Markus¹, Edgar, Chris¹, Garibaldi, George¹, Fontoura, Paulo¹, Santarelli, Luca¹
Source:	Neurobiology of Aging. Mar2016 Supplement, Vol. 39, pS28-S29. 1p.
Database:	Academic Search Ultimate

Description
ISSN:	01974580
DOI:	10.1016/j.neurobiolaging.2016.01.124